CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 379 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 1-25 of 379 matching filings.

Per page
25
Current page
1
EFFECT File 333-296033

EFFECT filing

Filing date
26 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-296033

424B3 PROSPECTUS

Filing date
26 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-584551

D filing

Filing date
19 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-296033

FORM S-3 REGISTRATION STATEMENT

Filing date
19 May 2026
Reporting date
Not listed
Next action
Verify source filing
SCHEDULE 13G/A File 005-93973

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39126

FORM 10-Q FOR MAR 2026

Filing date
14 May 2026
Reporting date
31 Mar 2026
Next action
Verify source filing
10-K/A File 001-39126

AMENDMENT #1 TO FORM 10-K

Filing date
30 Apr 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
SCHEDULE 13G File 005-93973

SCHEDULE 13G filing

Filing date
17 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39126

FORM 10-K FOR DEC 2025

Filing date
31 Mar 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
11 Mar 2026
Reporting date
11 Mar 2026
Next action
Verify source filing
4

4 filing

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93973

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jan 2026
Reporting date
01 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Jan 2026
Reporting date
01 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
17 Dec 2025
Reporting date
16 Dec 2025
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
21 Nov 2025
Reporting date
17 Nov 2025
Next action
Verify source filing
4

4 filing

Filing date
19 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .